Metoclopramide HCl 10 mg


Metolon® Tablet 10 mg, each tablet contains : Metoclopramide HCl monohydrate equivalent to Metoclopramide 10 mg.



Metolon® containing Metoclopramide HCl monohydrate (equivalent to Metoclopramide), which is available in tablet 10 mg, drops 2 mg/ml, syrup 5 mg/5 ml and injection 10 mg/2 ml.



  • Relief of metabolic nausea and vomiting caused by drug or post operative conditions.
  • Relief of symptoms associated with acute and recurrent gastroparesis.



Dosage recommendations given should be strictly followed to avoid dystonia side effects. Total daily dosage especially for children and adult should not exceed 0.5 mg/kgBW under normal circumstances. Dosage should be at reduced levels in patients with significant renal or hepatic impairment.

  • Adults of 20 years and older :

1 tablet of Metolon® Tablet or 2 measurement spoonfuls of Metolon® Syrup, 3 times daily, it may be used for patients with body weight > 60 kg. To avoid adverse reactions, patients should be strictly followed the dosage recommendations and patients should examine to the doctor if on prolonged therapy.

  • 15 – 19 years old :

Only use Metolon® carefully after examination to avoid masking an underlying disorder, such as cerebral irritation.

Weight 60 kg and over : 1 tablet of Metolon® Tablet or 2 measuring spoonfuls of Metolon® Syrup, 3 times daily.

Weight 30 – 59 kg : ½ tablet of Metolon® Tablet or 1 measuring spoonful of Metolon® Syrup, 3 times daily.

  • Children :

Tablet properties should not be given to children under 15 years, oral solution properties may be given to younger.

  • 9 – 14 years old (weight 30 kg and over) : 1 measuring spoonful of Metolon®
  • 5 – 9 years old (weight 20 – 29 kg) : ½ measuring spoonful of Metolon® Syrup (2½ mg), 3 times daily.
  • 3 – 5 years old (weight 15 – 19 kg) : 2 mg (1 ml of Metolon® Drops), 2 – 3 times daily.
  • Under 1 year old (weight 1 – 10 kg) : 1 mg (0.5 ml of Metolon® Drops), 2 times daily.



Metolon® is contraindicated for :

  • The stimulation of intestinal motility can be dangerous, such as : Gastrointestinal hemorrhage, mechanical obstruction, or perforation.
  • Patients with pheochromocytoma, because the drug may cause hypersensitive crisis.
  • Hypersensitivity or intolerance to Metoclopramide.
  • Epileptics or patients receiving other drugs which are likely cause extrapyramidal symptoms.



  • Metoclopramide can cause psycho interference.
  • Patients should be use with caution while operate machinery or driving or performing other tasks requiring alertness, coordination and physical dexterity.
  • Mental depression has occured in patients with and without a history depression. Give Metoclopramide to patients with a prior history of depression only if the expected benefits outweigh the potential risks.
  • Extrapyramidal symptoms can be occured. If this symptoms should occur, inject 50 mg Diphenhydramine HCl intramuscularly.
  • Parkinson-like symptoms have occured, more commonly within the first 6 months after beginning treatment with Metoclopramide but occasionally after longer periods. These symptoms generally subside within 2 – 3 months following discontinuance of Metoclopramide.
  • Use caution in hypertensive patients.
  • Metoclopramide is distributed into breast milk, however, exercise caution when administering to a nursing mother.
  • Use only when clearly needed and the potential benefits outweigh the potential hazards to the fetus.



Metolon® Tablet 10 mg Box, 10 strips @ 10 tablets Reg. No. DKL9002314210A1







Manufactured by :


Sidoarjo – Indonesia